Ouellet V, Erickson A, GAP1 UTMAs Contributing Investigators, Wiley K, Morrissey C, Berge V, Moreno CS, Tasken KA, Trudel D, True LD, Lewis MS, Svindland A, Ertunc O, Vidal ID, Osunkoya AO, Jones T, Bova GS, Lamminen T, Achtman AH, Buzza M, Kouspou MM, Bigler SA, Zhou X, Freedland SJ, Mes-Masson AMet al.(2022) The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource Cancer Epidemiol Biomarkers Prev, 31(4), 715-727 DOI 10.1158/1055-9965.EPI-21-0600, PubMed 35131885
Sivanesan S, Taskén KA, Grytli HH(2022) Association of β-Blocker Use at Time of Radical Prostatectomy With Rate of Treatment for Prostate Cancer Recurrence JAMA Netw Open, 5(1), e2145230 DOI 10.1001/jamanetworkopen.2021.45230, PubMed 35080602
Ramirez-Garrastacho M, Bajo-Santos C, Line A, Martens-Uzunova ES, de la Fuente JM, Moros M, Soekmadji C, Tasken KA, Llorente A(2021) Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research Br J Cancer, 126(3), 331-350 DOI 10.1038/s41416-021-01610-8, PubMed 34811504